Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Johnson & Johnson's Strong Performance Since Last Earnings Report Raises Expectations

February 28, 2025
Johnson & Johnson (JNJ) has shown an impressive 8.9% increase in its stock price since the release of its last earnings report. This positive momentum has investors wondering if the company can continue its upward trajectory.

One of the major factors contributing to JNJ's recent success is its resolve to combat the ongoing talc cancer litigation. The bankruptcy hearing has begun in Texas, and Johnson & Johnson is determined to protect its reputation and maintain its financial stability.

In addition, JNJ has filed a lawsuit against Samsung Bioepis for an unlawful sublicense of its popular drug, Stelara. This legal battle showcases Johnson & Johnson's commitment to protecting its intellectual property rights and ensuring fair competition in the pharmaceutical industry.

Observers are closely monitoring Johnson & Johnson's options market dynamics, as it provides valuable insights into investors' expectations for the company's future performance. Market analysts recommend consulting professionals from Stocks Prognosis for a detailed forecast on the movement of JNJ's stock.
If you want to leave a comment, then you need Login or Register





Other data for JNJ

Related data

JNJJuly 14, 2025Johnson & Johnson Innovates with New Product Launches  ~1 min.

Johnson & Johnson, a leading pharmaceutical company, continues to make waves in the industry with its latest submission of sNDA for the schizophrenia drug CAPLYTA to the FDA....

JNJMay 25, 2025Revolutionary Innovation: JNJ Johnson & Johnson Leads the Medical Industry with Groundbreaking Technology  ~1 min.

Johnson & Johnson, the renowned medical technology company, continues to be at the forefront of innovation in the industry....

JNJMarch 21, 2025Johnson & Johnson Neurovascular leader heads for the exit  ~1 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, has announced his departure from the company....

JNJMarch 20, 2025Johnson & Johnson Faces Shareholder Activism Over Human Rights and Executive Pay Proposals  ~2 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, is leaving the company, according to sources....

JNJMarch 19, 2025FDA Clears Johnson & Johnson Robot for Enhanced Bronchoscopy  ~1 min.

Johnson & Johnson's MedTech division has received clearance from the FDA for its enhanced robotic-assisted bronchoscopy system....

JNJMarch 18, 2025Johnson & Johnson MedTech Introduces New EP Neurovascular Leader  ~1 min.

Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....

JNJMarch 14, 2025Johnson & Johnson's Decades-Long Quest for Effective IBD Treatments  ~1 min.

Johnson & Johnson has been investing in research and development for decades in order to find effective treatments for inflammatory bowel disease (IBD)....

JNJFebruary 26, 2025The surgical devices I design for JJ speed healing and save lives  ~1 min.

Johnson & Johnson (JNJ) has been at the forefront of medical technology, constantly innovating and developing breakthrough surgical devices that not only speed up the healing process but also save lives....

JNJFebruary 18, 2025Johnson & Johnson reportedly wants to sell Cerenovus for 1B  ~1 min.

According to recent reports, Johnson & Johnson is considering selling its Cerenovus stroke business for 1 billion dollars....

JNJFebruary 16, 2025Johnson & Johnson Explores Sale of Cerenovus for $1 Billion  ~1 min.

According to reports, pharmaceutical giant Johnson & Johnson is looking to sell its stroke care business, Cerenovus, for a staggering $1 billion....

JNJNovember 6, 2024US Government Moves to Block JJ Talc Bankruptcy Resolution, Impacts JNJ Johnson & Johnson's Future  ~2 min.

JNJ Johnson & Johnson, a renowned pharmaceutical and consumer goods company, faces a major setback as the US government steps in to block JJ Talc's bankruptcy resolution....

JNJNovember 1, 2024Something Really Bad Happened: JJs Talc Bankruptcy Vote Under Attack  ~2 min.

In a shocking turn of events, Johnson & Johnson (JNJ) faced a major setback as its talc bankruptcy vote came under attack....

JNJNovember 4, 2024US Government Blocks JJ's Talc Bankruptcy Resolution, Stocks Prognosis Recommends to Buy  ~2 min.

JJ Johnson & Johnson's plans to resolve its talc bankruptcy issue have hit a roadblock as the US government intervenes....

JNJNovember 3, 2024US government moves to block JJ talc bankruptcy resolution  ~1 min.

The US government has taken legal action to block Johnson & Johnson's proposed bankruptcy resolution regarding its talc lawsuits. The company had offered an $8....

MUFebruary 16, 2025Intellectual Property Victory Boosts Micron Technology Inc. (MU) Stock  ~2 min.

Micron Technology Inc. (MU) recently achieved a significant milestone in its ongoing legal battle, securing a major victory in a long-standing intellectual property lawsuit....